Health Canada drug identification number

DIN 00504513 — MAGNESIUM SULFATE INJ 50% 500 MG

MAGNESIUM SULFATE INJ 50% is a liquid of Magnesium sulfate (oral) marketed by KRIPPS PHARMACY LTD.. The full Magnesium sulfate (oral) monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
00504513
Brand name
MAGNESIUM SULFATE INJ 50%
Active ingredient
Magnesium sulfate (oral)
Strength
500 MG
Dosage form
LIQUID
Route
INTRAMUSCULAR
Manufacturer
KRIPPS PHARMACY LTD.
Health Canada status
DORMANT
Drug class
Osmotic (saline) laxative

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Magnesium sulfate (oral) products

DINBrandStrengthFormManufacturerStatus
02542153 MAGNESIUM SULFATE IN WATER FOR INJECTION 40 MG SOLUTION BAXTER CORPORATION MARKETED
00392618 MAGNESIUM SULFATE INJECTION USP 200 MG SOLUTION SANDOZ CANADA INCORPORATED MARKETED
02562235 MAGNESIUM SULFATE INJECTION USP 500 MG SOLUTION STERIMAX INC MARKETED
02513161 MAGNESIUM SULFATE INJECTION, BP 49.3% 493 MG SOLUTION BAXTER CORPORATION MARKETED
02139499 MAGNESIUM SULFATE INJECTION, USP 500 MG SOLUTION FRESENIUS KABI CANADA LTD MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.